Transjugular liver biopsy for Fontan associated liver disease surveillance: Technique, outcomes and hemodynamic

Alejandro A Borquez1, Jose Silva-Sepulveda1, Jesse W Lee1

  • 1San Diego School of Medicine, Department of Pediatrics, Division of Pediatric Cardiology, University of California, USA.

Insights

Transjugular liver biopsies (TJLB) offer a safe and effective method for Fontan associated liver disease (FALD) surveillance. This technique correlates well with hemodynamic parameters, aiding in FALD management.

Area of Science:

  • Cardiology
  • Hepatology
  • Interventional Radiology

Background:

  • Fontan associated liver disease (FALD) arises from Fontan circulation limitations, causing congestive hepatopathy.
  • Rigorous surveillance is crucial for managing FALD in Fontan patients.
  • Transjugular liver biopsy (TJLB) is a potential surveillance tool.

Purpose of the Study:

  • To define the technique and outcomes of TJLB in Fontan patients.
  • To assess TJLB as part of a FALD surveillance program.
  • To correlate biopsy findings with hemodynamic data.

Main Methods:

  • A four-year review of 125 Fontan physiology patients undergoing TJLB.
  • Analysis of biopsy site, technique, histology, angiography, hemodynamics, and complications.
  • Correlation of modified Ishak congestive hepatic fibrosis (ICHF) scores with catheterization hemodynamics.

Main Results:

  • 100% technical success with diagnostic samples in all patients.
  • A 3.2% complication rate, primarily early in the experience and avoidable.
  • Significant correlation found between ICHF score, mean Fontan pressure, time from Fontan, and cardiac index.

Conclusions:

  • TJLB is a viable alternative for FALD surveillance with low complication rates.
  • Vascular anomalies in Fontan physiology necessitate pre-biopsy assessment.
  • TJLB findings correlate significantly with key hemodynamic and temporal factors.
Abstract

Related Concept Videos